Schedule 13D ownership disclosure

Arbutus Biopharma Corp

Security class unavailable · CUSIP: 03879J100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,013,540
Percent of class
28.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-040589
Form type
SC 13D/A
Filer
Arbutus Biopharma Corp
CIK
CIK 1447028
Filed
Jul 16, 2019
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub